Published in Mult Scler Int on May 14, 2014
Aspirin for Treatment of Multiple Sclerosis-Related Fatigue | NCT00467584
Qigong for Multiple Sclerosis: A Feasibility Study | NCT04585659
Clinically significant fatigue: prevalence and associated factors in an international sample of adults with multiple sclerosis recruited via the internet. PLoS One (2015) 0.87
Management of fatigue in persons with multiple sclerosis. Front Neurol (2014) 0.83
The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue. EPMA J (2016) 0.79
Functional and structural balances of homologous sensorimotor regions in multiple sclerosis fatigue. J Neurol (2014) 0.77
Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study. BMC Neurol (2016) 0.75
Cardiovascular Dysfunction in Multiple Sclerosis. Maedica (Buchar) (2015) 0.75
Perceptions of Participants in a Group, Community, Exercise Programme for People with Multiple Sclerosis. Rehabil Res Pract (2015) 0.75
Evaluation of a Fatigue Self-Management Program for People with Multiple Sclerosis. Int J MS Care (2016) 0.75
Effectiveness of Group Versus Individual Yoga Exercises on Fatigue of Patients with Multiple Sclerosis. N Am J Med Sci (2015) 0.75
Patient education for people with multiple sclerosis-associated fatigue: A systematic review. PLoS One (2017) 0.75
Development and Feasibility of an Evidence-Based Patient Education Program for Managing Fatigue in Multiple Sclerosis: The "Fatigue Management in MS" Program (FatiMa). Int J MS Care (2016) 0.75
Effect of exercise therapy on quality of life of patients with multiple sclerosis in Iran: a systematic review and meta-analysis. Neurol Sci (2017) 0.75
Fatigue as a symptom or comorbidity of neurological diseases. Nat Rev Neurol (2017) 0.75
A power primer. Psychol Bull (1992) 63.66
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology (1983) 40.64
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (2011) 29.14
The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol (1989) 13.32
Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care (2001) 10.79
Self-management approaches for people with chronic conditions: a review. Patient Educ Couns (2002) 8.66
Scoping studies: advancing the methodology. Implement Sci (2010) 7.82
Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis (1994) 3.59
Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. Neurology (2005) 2.95
Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology (1995) 2.90
MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial. Neurology (2010) 2.33
Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology (2004) 2.20
How to select, calculate, and interpret effect sizes. J Pediatr Psychol (2009) 2.15
Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J Neurol Sci (2002) 1.91
Exercise therapy for multiple sclerosis. Cochrane Database Syst Rev (2005) 1.69
Interventions to improve chronic illness care: evaluating their effectiveness. Dis Manag (2003) 1.65
Fatigue associated with multiple sclerosis: diagnosis, impact and management. Mult Scler (2003) 1.60
What does a structured review of the effectiveness of exercise interventions for persons with multiple sclerosis tell us about the challenges of designing trials? Mult Scler (2009) 1.59
Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey. Health Qual Life Outcomes (2008) 1.56
Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler (2000) 1.54
A randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue. Psychosom Med (2008) 1.50
Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Mult Scler (2002) 1.39
A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis. Neurology (2005) 1.26
The relationship of sleep disturbances and fatigue in multiple sclerosis. Arch Neurol (2004) 1.20
Effects of treatment for depression on fatigue in multiple sclerosis. Psychosom Med (2003) 1.14
Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis. Clin Neurol Neurosurg (2010) 1.09
Amantadine for fatigue in multiple sclerosis. Cochrane Database Syst Rev (2007) 1.09
Randomized controlled trial of an energy conservation course for persons with multiple sclerosis. Mult Scler (2005) 1.07
Fatigue, mood and quality of life improve in MS patients after progressive resistance training. Mult Scler (2010) 1.07
Effects of exercise training on fatigue in multiple sclerosis: a meta-analysis. Psychosom Med (2013) 1.06
Symptomatic therapy and neurorehabilitation in multiple sclerosis. Lancet Neurol (2005) 1.05
Treadmill training for individuals with multiple sclerosis: a pilot randomised trial. J Neurol Neurosurg Psychiatry (2006) 1.04
Effects of vestibular rehabilitation on multiple sclerosis-related fatigue and upright postural control: a randomized controlled trial. Phys Ther (2011) 1.03
Cycling progressive resistance training for people with multiple sclerosis: a randomized controlled study. Am J Phys Med Rehabil (2010) 1.02
Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial. J Neurol Sci (2004) 1.01
Multidisciplinary fatigue management programme in multiple sclerosis: a randomized clinical trial. Mult Scler (2007) 1.00
A pilot randomised controlled trial of an Internet-based cognitive behavioural therapy self-management programme (MS Invigor8) for multiple sclerosis fatigue. Behav Res Ther (2012) 0.99
HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis. Mult Scler (2011) 0.98
Randomized trial of a teleconference-delivered fatigue management program for people with multiple sclerosis. Mult Scler (2011) 0.97
Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine. Mult Scler (2001) 0.97
Disability rating scales in multiple sclerosis. Ann N Y Acad Sci (1984) 0.96
Comparison of the psychometric properties of two fatigue scales in multiple sclerosis. Rehabil Psychol (2012) 0.94
Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study. Neurol Res (2012) 0.92
Clinical trial of a formal group fatigue program in multiple sclerosis. Mult Scler (2010) 0.91
Effectiveness of energy conservation treatment in reducing fatigue in multiple sclerosis: a systematic review and meta-analysis. Arch Phys Med Rehabil (2013) 0.90
Overview of clinical trials in medical rehabilitation: impetuses, challenges, and needed future directions. Am J Phys Med Rehabil (2003) 0.88
Effect of precooling on physical performance in multiple sclerosis. Mult Scler (2000) 0.87
Effects of high-intensity resistance training on strength, mobility, balance, and fatigue in individuals with multiple sclerosis: a randomized controlled trial. J Neurol Phys Ther (2011) 0.87
Effect of aquatic exercise training on fatigue and health-related quality of life in patients with multiple sclerosis. Arch Phys Med Rehabil (2012) 0.86
A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis. The Canadian MS Research Group. Can J Neurol Sci (1987) 0.84
Effect of inspiratory muscle training in patients with multiple sclerosis. Arch Phys Med Rehabil (2003) 0.83
Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis? Neurol Neurochir Pol (2010) 0.82
Fatigue and heat sensitivity in patients with multiple sclerosis. Acta Neurol Scand (2012) 0.79
Pharmacologic treatments for fatigue associated with palliative care. Clin J Oncol Nurs (2011) 0.76